Prednisone Does Not Directly Increase MCV or MCH
Prednisone itself does not cause increases in mean corpuscular volume (MCV) or mean corpuscular hemoglobin (MCH). The FDA drug label for prednisone does not list macrocytosis or elevated red blood cell indices as adverse effects 1. When elevated MCV/MCH occur in patients on prednisone, this reflects other underlying causes rather than a direct drug effect.
Understanding the Context
The confusion likely arises because prednisone is frequently used in combination chemotherapy regimens (such as MOPP for Hodgkin's disease), and these cytotoxic agents—not the prednisone component—cause MCV elevation. Studies examining MOPP therapy (mechlorethamine, vincristine, procarbazine, and prednisone) demonstrate significant MCV increases during treatment 2, 3, but this effect is attributable to the alkylating agents and procarbazine, which damage bone marrow and alter erythropoiesis.
Key Mechanistic Points:
- Cytotoxic chemotherapy agents cause macrocytosis by disrupting DNA synthesis in erythroid precursors, leading to larger red blood cells
- Prednisone is a glucocorticoid that modulates inflammation and immune responses but does not interfere with red cell maturation or hemoglobin synthesis
- The GFHC guidelines on MCHC management do not list corticosteroids as causes of elevated red cell indices 4
What Actually Causes Elevated MCV/MCH
When evaluating macrocytosis in any patient (including those on prednisone), the diagnostic workup should focus on 5, 6:
Primary causes to investigate:
- Vitamin B12 or folate deficiency (most common nutritional cause)
- Thiopurine medications (azathioprine, 6-mercaptopurine) - these are well-established causes
- Alcohol abuse
- Hypothyroidism
- Reticulocytosis (from hemolysis or bleeding)
- Myelodysplastic syndromes
- Liver disease
In chemotherapy contexts specifically:
- Alkylating agents (mechlorethamine, melphalan, cyclophosphamide)
- Antimetabolites affecting DNA synthesis
- The degree of MCV elevation during cytotoxic therapy may predict bone marrow damage and secondary leukemia risk 2, 3
Clinical Implications
If you observe elevated MCV/MCH in a patient taking prednisone:
- Do not attribute it to the prednisone - search for alternative causes
- Check B12, folate, and thyroid function as initial screening 5, 7
- Review all medications for known causes of macrocytosis (particularly thiopurines, methotrexate)
- Assess for alcohol use and liver disease
- Evaluate reticulocyte count to distinguish regenerative from hypoproliferative causes 8
- In inflammatory bowel disease patients on both prednisone and thiopurines, the macrocytosis is from the thiopurine, not the steroid 5
Important Caveat
In patients receiving combination chemotherapy regimens containing prednisone, monitor MCV trends carefully. Rapid or excessive MCV increases (>24 fl total increase, or >15 fl over 3 months) may indicate heightened bone marrow toxicity and increased risk of therapy-related leukemia 2, 3. However, this reflects the cytotoxic components of the regimen, not the prednisone.
The bottom line: prednisone is not a cause of macrocytosis or elevated MCH—look elsewhere for the explanation when these findings occur.